^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

KF-1601

i
Other names: KF-1601
News
Trials
Company:
ImmunoForge
Drug class:
Bcr-abl tyrosine kinase inhibitor, FLT3 inhibitor
Related drugs:
News
Trials